SITEMAP
ARMY.MIL
AKO
SEARCH
About USAMRIID
Scientific Publications
Medical Library
Business Opportunities
Employment
Education & Training
Biosafety
Reference Materials
Related Links
Newsroom/Media
Contact Us
Search
>> Home >> Scientific Publications >> 2011
2012 • 2011 • 2010 • 2009 • 2008 • 2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001 • 2000
— 2011 —
Akhvlediani T, Ellis MW, Rivard R, Zenaishvili O, Battafarano DJ, Hepburn MJ. A review of the English and Russian language literature on the osteoarticular manifestations of brucellosis infection. Current Rheumatology Reviews 2011, 7(3): 263-271.
Badger CV, Richardson JD, DaSilva RL, Richards MJ, Josleyn MD, Dupuy LC, Hooper JW, Schmaljohn CS. Development and application of a flow cytometric potency assay for DNA vaccines. Vaccine 2011 Sept 9, 29(39): 6728-6735
Bahta M, Lountos GT, Dyas B, Kim SE, Ulrich RG, Waugh DS, Burke TR. Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase. Journal of Medicinal Chemistry 2011 Apr 28; 54(8): 2933-43
Basu A; Li B; Mills DM; Panchal RG; Cardinale SC; Butler MM; Peet NP; Majgier-Baranowska H; Williams JD; Patel I; Moir DT; Bavari S; Ray R; Farzan MR; Rong LJ; Bowlin TL. Identification of a small-molecule entry inhibitor for filoviruses. Journal of Virology 2011 Apr, 85(7): 3106-3119
Bondugula R, Wallqvist A, Lee MS. Can computationally designed protein sequences improve secondary structure prediction? Protein Engineering Design & Selection 2011 May; 24(5): 455-61
Bozue J, Mou S, Moody KL, Cote CK, Trevino S, Fritz D, Worsham P. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis. Microbial Pathogenesis 2011 June; 50(6): 314-21
Bradfute SB, Bavari S. Correlates of Immunity to Filovirus Infection. Viruses 2011 July, 3(7): 982-1000
Bradfute SB, Dye JM, Bavari S. Filovirus vaccines. Human Vaccines 2011 June; 7 (6): 701-711
Bradfute SB, Stuthman KS, Shurtleff AC, Bavari S. A STAT-1 knockout mouse model for Machupo virus pathogenesis. Virology Journal 2011 June 14; 8: 300
Brett PJ; Burtnick MN; Heiss C; Azadi P; DeShazer D; Woods DE; Gherardini FC. Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides. Infection and Immunity 2011 Feb, 79(2): 961-969
Burke RL, Vest KG, Eick AA, Sanchez JL, Johns MC, Pavlin JA, Jarman RG, Mothershead JL, Quintana M, Palys T, Cooper MJ, Guan J, Schnabel D, Waitumbi J, Wilma A, Daniels C, Brown ML, Tobias S, Kasper MR, Williams M, Tjaden JA, Oyofo B, Styles T, Blair PJ, Hawksworth A, Montgomery JM, Razuri H, Laguna-Torres A, Schoepp RJ, Norwood DA, MacIntosh VH, Gibbons T, Gray GC, Blazes DL, Russel, KL. Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic. BMC Public Health 2011 Mar 4; 11 (Suppl. 2): S6
Burtnick MN; Brett PJ; Harding SV; Ngugi SA; Ribot WJ; Chantratita N; Scorpio A; Milne TS; Dean RE; Fritz DL; Peacock SJ; Prior JL; Atkins TP; Deshazer D. The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infection and Immunity 2011 Apr, 79(4): 1512-25
Cardellina JH, Vieira RC, Eccard V, Skerry J, Montgomery V, Campbell Y, Roxas-Duncan V, Leister W, Leclair CA, Maloney DJ, Padula D, Pescitelli G, Khavrutskii I, Hu X, Wallqvist A, Smith LA. Separation of betti reaction produt enantiomers: Absolute configuration and inhibition of botulinum neurotoxin A. ACS Medicinal Chemistry Letters 2011 May 12; 2(5): 396-401
Cardinale SC, Butler MM, Ruthel G, Nuss J, Wanner LM, Li B, Pai RP, Peet NP, Bavari S, Bowlin TL. Novel benzimidazole inhibitors of botulinum neurotoxin/A display enzyme and cell-based potency. Botulinum Journal 2011 2(1): 16-29
Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 2011 Sept 15, 477(7364): 340-43
Carman RJ, Stevens AL, Lyerly MW, Hiltonsmith MF, Stiles BG, Wilkins TD. Clostridium difficile binary toxin (CDT) and diarrhea. Anaerobe 2011 Aug, 17(4): 161-165
Cashman KA; Smith MA; Twenhafel NA; Larson RA; Jones KF; Allen RD; Dai D; Chinsangaram J; Bolken TC; Hruby DE; Amberg SM; Hensley LE; Guttieri MC. Evaluation of Lassa antiviral compound ST-193 in a guinea pig model. Antiviral Research 2011 Apr, 90(1): 70-9
Chanturia G, Birdsell DN, Kekelidze M, Zhgenti E, Babuadze G, Tsertsvadze N, Tsanava S, Imnadze P, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, Champion MD, Sinari S, Gyuranecz M, Farlow J, Pettus AH, Kaufman EL, Busch JD, Pearson T, Foster JT, Vogler AJ, Wagner DM, Keim P. Phylogeography of Francisella tularensis subspecies holarctica from the country of Georgia. BMC Microbiology 2011 June 17; 11: 139
Chappell MG; Koeller CA; Hall Shannan I. Differences in Postsurgical Recovery of CF1 Mice after Intraperitoneal implantation of radiotelemetry devices through a midline or flank surgical approach. Journal of the American Association for Laboratory Animal Science - JAALAS 2011, 50(2): 227-37
Choe H, Jemielity S, Abraham J, Radoshitzky SR, Farzan M. Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses. Current Opinion in Microbiology 2011 Aug, 14(4): 476-482
Choksi KB, Nuss JE, DeFord JH, Papaconstantinou J. Mitochondrial electron transport chain functions in long-lived Ames dwarf mice. Aging (Albany NY). 2011 Aug;3(8):754-67
Clemens KA;, Larsen LB; Zhang MA ; Kuznetsov YC;, Bilanchone VA;, Randall AD; Harned AF; DaSilva RF; Nagashima KF; McPherson AB; Baldi PC; Sandmeyer, SA. The TY3 Gag3 spacer controls intracellular condensation and uncoating. Journal of Virology 2011 Apr, 85(7): 3055-3066
Compton JR; Legler PM; Clingan BV; Olson MA; Millard CB. Introduction of a disulfide bond leads to stabilization and crystallization of a ricin immunogen. Proteins 2011 Apr, 79(4): 1048-1060
Cote M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 2011 Sept 15, 477(7364): 344-48
Cote CK, Welkos SL, Bozue J. Key aspects of the molecular and cellular basis of inhalational anthrax. Microbes and Infection 2011 Dec, 13(14-15): 1146-55
Dabisch PA; Kline J. Symp IIId Respiration Measures and Toxicology Affect assessment in the primate: Mechanisms of injury and physiological responses from selected biological agents. International Journal of Toxicology 2011 Feb, 30(1): 118 (31st Annual Meeting of the American-College-of-Toxicology Baltimore, MD, 7-11 Nov 2010)
Dias JM, Kuehne AI, Abelson DM, Bale S, Wong AC, Halfmann P, Muhammad MA, Fusco ML, Zak SE, Kang E, Kawaoka Y, Chandran K, Dye JM, Saphire EO. A shared structural solution for neutralizing ebolaviruses. Nature Structural & Molecular Biology 2011 Nov 20; 18(12): 1424-7
Dower K, Rubins KH, Hensley LE, Connor JH. Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expression. Antiviral Research 2011 July; 91(1): 72-80
Dupuy LC, Richards MJ, Ellefsen B, Chau L, Luxembourg A, Hannaman D, Livingston BD, Schmaljohn CS. A DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates. Clinical and Vaccine Immunology 2011 May; 18(5): 707-16
Dux MP; Huang JC; Barent R; Inan M; Swanson ST; Sinha J; Ross JT; Smith LA; Smith TJ; Henderson I; Meagher MM. Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC(H-c)] expressed in Pichia pastoris. Protein Expression and Purification 2011 Feb, 75(2): 177-185
Embers ME; Doyle LA; Whitehouse CA; Selby EB; Chappell M; Philipp MT. Characterization of a Moraxella species that causes epistaxis in macaques. Veterinary Microbiology 2011 Jan 27, 147(3-4): 367-375
Ergunay K, Whitehouse CA, Ozkul A. Current status of human arboviral diseases in Turkey. Vector-Borne and Zoonotic Diseases 2011; 11(6): 731-741
Fernandez S, Cisney ED, Hall SI, Ulrich RG. Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue. Clinical and Vaccine Immunology 2011 Apr; 18(4): 667-75
Fernandez S, Cisney ED, Tikhonov AP, Schweitzer B, Putnak RJ, Simmons M, Ulrich RG. Antibody recognition of the Dengue virus proteome and implications for development of vaccines. Clinical and Vaccine Immunology 2011 Apr; 18(4): 523-32
Froude JW, Stiles B, Pelat T, Thullier P. Antibodies for biodefense. mAbs 2011 Nov; 3(6): 517–27
Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen, W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Engineering Design & Selection 2011 Mar, 24(3): 321-331
Geisbert TW, Bailey M, Hensley L, Asiedu C, Geisbert J, Stanley D, Honko A, Johnson J, Mulangu S, Pau MG, Custers J, Vellinga J, Hendriks J, Jahrling P, Roederer M, Goudsmit J, Koup R, Sullivan NJ. Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against Ebolavirus challenge. Journal of Virology 2011 May; 85(9): 4222-33
Gibert M; Monier MN; Ruez R; Hale ML; Stiles BG; Benmerah A; Johannes L; Lamaze C; Popoff MR. Endocytosis and toxicity of clostridial binary toxins depend on a clathrin-independent pathway regulated by Rho-GDI. Cellular Microbiology 2011 Jan, 13(1): 154-170
Goff A, Mucker E, Raymond J, Fisher R, Bray M, Hensley L, Paragas J. Infection of cynomolgus macaques with a recombinant monkeypox virus encoding green fluorescent protein. Archives of Virology 2011 Oct, 156(10): 1877-1881
Goff AJ; Chapman J; Foster C; Wlazlowski C; Shamblin J; Lin K; Kreiselmeier N; Mucker E; Paragas J; Lawler J; Hensley L. A novel respiratory model of infection with monkeypox virus in cynomolgus macaques. Journal of Virology 2011 May, 85(10): 4898-909 PMID: 21389129
Golden JW, Hooper JW. The strategic use of novel smallpox vaccines in the post-eradication world. Expert Review of Vaccines 2011 July, 10(7): 1021-1035
Golden JW, Zaitseva M, Kapnick S, Fisher RW, Mikolajczyk MG, Ballantyne J, Golding H, Hooper JW. Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease. Virology Journal 2011 Sept 20, 8: 441
Goodchild SA, Dooley H, Schoepp RJ, Flajnik M, Lonsdale SG. Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries. Molecular Immunology 2011 Sept, 48 (15-16): 2027-2037
Goodin JL; Powell BS; Enama JT; Raab RW; McKown RL; Coffman GL; Andrews GP. Purification. and characterization of a recombinant Yersinia pestis V-F1 "Reversed" fusion protein for use as a new subunit vaccine against plague. Protein Expression and Purification 2011 Mar 2011, 76(1): 136-44
Grant-Klein RJ, Altamura LA, Schmaljohn CS. Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses. Virus Research 2011 Dec, 162(1-2): 148-61
Grove JN, Branco LM, Boisen ML, Muncy IJ, Henderson LA, Schieffellin JS, Robinson JE, Bangura JJ, Fonnie M, Schoepp RJ, Hensley LE, Seisay A, Fair JN, Garry RF. Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: Case Report. Virology Journal 2011 June 20, 8: 314
Gunther S, Feldmann H, Geisbert TW, Hensley LE, Rollin PE, Nichol ST, Stroher U, Artsob H, Peters CJ, Ksiazek TG, Becker S, ter Meulen J, Olschlager S, Schmidt-Chanasit J, Sudeck H, Burchard GD, Schmiedel S. Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany. Journal of Infectious Diseases 2011 Nov; 204(Suppl 3): S785-S790
Guo HT; Pan XB; Mao RC; Zhang XC; Wang LJ; Lu XY; Chang JH; Guo JT; Passic S; Krebs FC; Wigdahl B; Warren TK; Retterer CJ; Bavari S; Xu XD; Cuconati A; Block TM. Alkylated porphyrins have broad antiviral activity against Hepadnaviruses, Flaviviruses, Filoviruses, and Arenaviruses. Antimicrobial Agents and Chemotherapy 2011 Feb, 55(2): 478-486
Hale M; Oyler G; Swaminathan S; Ahmed SA. Basic tetrapeptides as potent intracellular inhibitors of type a botulinum neurotoxin protease activity. Journal of Biological Chemistry 2011 Jan 21, 286(3): 1802-11
Hammerbeck CD, Hooper JW. T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome. Journal of Virology 2011 Oct, 85(19): 9929-44
Hensley LE, Alves DA, Geisbert JB, Fritz EA, Reed C, Larsen T, Geisbert TW. Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. Journal of Infectious Diseases 2011 Nov, 204 (Suppl 3): S1021-31
Hensley LE, Smith MA, Geisbert JB, Fritz EA, Daddario-Dicaprio KM, Larsen T, Geisbert TW. Pathogenesis of Lassa fever in cynomolgus macaques. Virology Journal 2011 May 6; 8: 205
Honsell G, De Bortoli M, Boscolo S, Dell'Aversano C, Battocchi C, Fontanive G, Penna A, Berti F, Sosa S, Yasumoto T, Ciminiello P, Poli M, Tubaro A. Harmful Dinoflagellate Ostreopsis cf. ovata Fukuyo: Detection of Ovatoxins in Field Samples and Cell lmmunolocalization Using Antipalytoxin Antibodies. Environmental Science and Technology 2011 Aug 15, 45(16): 7051-7059
Huang IC; Bailey CC; Weyer JL; Radoshitzky SR; Becker MM; Chiang JJ; Brass AL; Ahmed AA; Chi XL; Dong LA; Longobardi LE; Boltz D; Kuhn JH; Elledge SJ; Bavari S; Denison MR; Choe H; Farzan M. Distinct patterns of IFITM-mediated restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus. PloS Pathogens 2011 Jan, 7(1): e1001258
Ibrahim SM, Aitichou M, Hardick J, Blow J, O'Guinn ML, Schmaljohn C. Detection of Crimean-Congo hemorrhagic fever, Hanta, and sandfly fever viruses by real-time RT-PCR. Methods in molecular biology 2011; 665: 357-368
Iranpour M, Turell MJ, Lindsay LR. Potential for Canadian mosquitoes to transmit rift valley fever virus 1. Journal of the American Mosquito Control Association 2011 Dec; 27(4): 363-369
Janelidze N, Jaiani E, Lashkhi N, Tskhvediani A, Kokashvili T, Gvarishvili T, Jgenti D, Mikashavidze E, Diasamidze R, Narodny S, Obiso R, Whitehouse CA, Huq A, Tediashvili M. Microbial water quality of the Georgian coastal zone of the Black Sea. Marine Pollution Bulletin 2011 Mar; 62(3): 573-80
Jenkins A; Cote C; Twenhafel N; Merkel T; Bozue J; Welkos S. Role of purine biosynthesis in Bacillus anthracis pathogenesis and virulence. Infection and Immunity 2011 Jan, 79(1): 153-66
Kalb SR; Baudys J; Egan C; Smith TJ; Smith LA; Pirkle JL; Barr JR. Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxins. Applied and Environmental Microbiology 2011 Feb, 77(4): 1301-1308
Kalb SR, Santana WI, Geren IN, Garcia-Rodriguez C, Lou JL, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR. Extraction and inhibition of enzymatic activity of botulinum neurotoxins/B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies. BMC Biochemistry 2011 Nov 15; 12: 58
Keshtkar-Jahromi M, Kuhn JH, Christova I, Bradfute SB, Jahrling PB, Bavari, S. Crimean-Congo hemorrhagic fever: Current and future prospects of vaccines and therapies. Antiviral Research 2011 May; 90(2): 85-92
Kim HC, Klein TA, Kang HJ, Gu SH, Moon SS, Baek LJ, Chong ST, O'Guinn ML, Lee JS, Turell MJ, Song JW. Ecological surveillance of small mammals at Dagmar North Training Area, Gyeonggi Province, Republic of Korea, 2001-2005. Journal of Vector Ecology 2011 June; 36(1): 42-54
Kim SE, Bahta M, Lountos GT, Ulrich RG, Burke TR, Waugh DS. Isothiazolidinone (IZD) as a phosphoryl mimetic in inhibitors of the Yersinia pestis protein tyrosine phosphatase YopH. Acta Crystallographica Section D: Biological Crystallography 2011 July; 67(7): 639-645
Kiris E, Nuss JE, Burnett JC, Kota KP, Koh DC, Wanner LM, Torres-Melendez E, Gussio R, Tessarollo L, Bavari S. Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery. Stem Cell Research 2011 May; 6(3): 195-205
Kissner TL, Moisan L, Mann E, Alam S, Ruthel G, Ulrich RG, Rebek M, Rebek J, Saikh KU. A Small Molecule That Mimics the BB-loop in the Toll Interleukin-1 (IL-1) Receptor Domain of MyD88 Attenuates Staphylococcal Enterotoxin B-induced Pro-inflammatory Cytokine Production and Toxicity in Mice. Journal of Biological Chemistry 2011 Sept 9, 286(36): 31385-31396
Kissner TL; Ruthel G; Alam S; Ulrich RG; Fernandez S; Saikh KU. Activation of MyD88 signaling upon Staphylococcal Enterotoxin binding to MHC class II molecules. PLoS One 2011 Jan 20, 6(1): e15985
Kissner TL, Ruthel G, Cisney ED, Ulrich RG, Fernandez S, Saikh KU. MyD88-dependent pro-inflammatory cytokine response contributes to lethal toxicity of staphylococcal enterotoxin B in mice. Innate Immunity 2011 Oct, 17(5): 451-462
Klein TA, Kang HJ, Gu SH, Moon S, Shim S-H, Park YM, Lee S-Y, Kim H-C, Chong S-T, O'Guinn M, Lee JS, Turell MJ, Song J-W. Hantaan virus surveillance targeting small mammals at Dagmar North Training Area, Gyeonggi Province, Republic of Korea, 2001-2005. Journal of Vector Ecology 2011 Dec; 36(2): 373-381
Koehler JW, Dupuy LC, Garrison AR, Beitzel BF, Richards MJ, Ripoll DR, Wallqvist A, Teh SY, Vaewhongs AA, Vojdani FS, Padgett HS, Schmaljohn CS. Novel plant-derived recombinant human interferons with broad spectrum antiviral activity. Antiviral Research 2011 Dec, 92(3): 461-9
Konduru K, Bradfute SB, Jacques J, Manangeeswaran M, Nakamura S, Morshed S, Wood SC, Bavari S, Kaplan GG. Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice. Vaccine 2011 Apr 5; 29(16): 2968-77
Kortepeter MG, Lawler JV, Honko A, Bray M, Johnson JC, Purcell BK, Olinger GG, Rivard R, Hepburn MJ, Hensley LE. Real-time Monitoring of Cardiovascular Function in Rhesus Macaques Infected With Zaire ebolavirus. Journal of Infectious Diseases 2011 Nov; 204(Suppl 3): S1000-S1010
Kuhn JH, Dodd LE, Wahl-Jensen V, Radoshitzky SR, Bavari S, Jahrling PB. Evaluation of perceived threat differences posed by filovirus variants. Biosecurity and Bioterrorism 2011 Dec; 9(4): 361-371
Lee MS, Olson MA. Comparison of two adaptive temperature-based replica exchange methods applied to a sharp phase transition of protein unfolding-folding. Journal of Chemical Physics 2011 June 28; 134(24): 244111
Leslie T, Whitehouse CA, Yingst S, Baldwin C, Kakar F, Mofleh J, Hami AS, Mustafa L, Omar F, Ayazi E, Rossi C, Noormal B, Ziar N, Kakar R. Outbreak of gastroenteritis caused by Yersinia pestis in Afghanistan. Epidemiology and Infection 2011 May 11; 139(5): 728-35
Li B, Cardinale SC, Butler MM, Pai R, Nuss JE, Peet NP, Bavari S, Bowlin TL. Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors. Bioorganic & Medicinal Chemistry 2011 Dec 15; 19(24): 7338-48
Little SF; Webster WM; Fisher DE. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo. FEMS Immunology and Medical Microbiology 2011 June, 62 (1): 11-22
Lofts LL; Wells JB; Bavari S; Warfield KL. Key genomic changes necessary for an in vivo lethal mouse Marburgvirus variant selection process. Journal of Virology 2011 Apr, 85(8): 3905-3917
Lonsway DR, Urich SK, Heine HS, McAllister SK, Banerjee SN, Schriefer ME, Patel JB. Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis. Journal of Clinical Microbiology 2011 May; 49(5): 1956-60
Louie A; Heine HS; VanScoy B; Eichas A; Files K; Fikes S; Brown DL; Liu W; Kinzig-Schippers M; Sorgel F; Drusano GL. Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance. Antimicrobial Agents and Chemotherapy 2011 Feb, 55(2): 822-830
Louie A, VanScoy B, Liu WG, Kulawy R, Brown D, Heine HS, Drusano GL. Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model. Antimicrobial Agents and Chemotherapy 2011 June; 55(6): 2623-2628
Lutomiah JL, Koka H, Mutisya J, Yalwala S, Muthoni M, Makio A, Limbaso S, Musila L, Clark JW, Turell MJ, Kioko E, Schnabel D, Sang RC. Ability of Selected Kenyan Mosquito (Diptera: Culicidae) Species to Transmit West Nile Virus Under Laboratory Conditions. Journal of Medical Entomology 2011 Nov; 48(6): 1197-1201
Macdonald TE, Helma CH, Shou Y, Valdez YE, Ticknor LO, Foley BT, Davis SW, Hannet, GE, Kelly-Cirino CD, Barash JR, Arnon SS, Lindström M, Korkeala H, Smith LA, Smith TJ, Hill KK. Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing. Applied and Environmental Microbiology 2011 Dec; 77(24): 8625-8634
Majumdar S, Ford BM, Mar KD, Sullivan VJ, Ulrich RG, D'Souza AJ. Evaluation of the effect of syringe surfaces on protein formulations. Journal of Pharmaceutical Sciences 2011 July; 100(7): 2563-2573
McLain DE, Horn TL, Detrisac CJ, Lindsey CY, Smith LA. Progress in Biological Threat Agent Vaccine Development: A repeat-dose toxicity study of a recombinant ricin toxin A-chain (rRTA) 1-33/44-198 vaccine (RVEc) in male and female New Zealand White Rabbits. International Journal of Toxicology 2011 Mar; 30(2): 143-52
Meagher MM, Seravalli JG, Swanson ST, Ladd RG, Khasa YP, Inan M, Harner JC, Johnson SK, Van Cott K, Lindsey C, Wannemacher R, Smith LA. Process Development and cGMP Manufacturing of a Recombinant Ricin Vaccine: an Effective and Stable Recombinant Ricin A-Chain Vaccine-RVEc (TM). Biotechnology Progress 2011 July-Aug, 27(4): 1036-1047
Mease LE, Coldren RL, Musila LA, Prosser T, Ogolla F, Ofula VO, Schoepp RJ, Rossi CA, Adungo N. Seroprevalence and distribution of arboviral infections among rural Kenyan adults: A cross-sectional study. Virology Journal 2011 July 27, 8:371
Michelow IC; Lear C; Scully C; Prugar LI; Longley CB; Yantosca LM; Ji X; Karpel M; Brudner M; Takahashi K; Spear GT; Ezekowitz RAB; Schmidt EV; Olinger GG. High-dose mannose-binding lectin therapy for Ebola virus infection. Journal of Infectious Diseases 2011 Jan 15, 203(2): 175-179
Miller EH, Harrison JS, Radoshitzky SR, Higgins CD, Chi X, Dong L, Kuhn JH, Bavari S, Lai JR, Chandran K. Inhibition of Ebola virus entry by a C-peptide targeted to endosomes. Journal of Biological Chemistry 2011 May 6; 286(18): 15854–61
Montgomery VA, Smith LA. Diagnostic and Possible Therapeutic Application of a Monoclonal Antibody (14G8) Directed Against botulinum Type C Neurotoxin. Hybridoma 2011 June; 30(3): 209-16
Morrill JC, Peters CJ. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent Rift Valley fever virus. Journal of Infectious Diseases 2011 July 15; 204(2): 229-236
Mustafa ML, Ayazi E, Mohareb E, Yingst S, Zayed A, Rossi CA, Schoepp RJ, Mofleh J, Fiekert K, Akhbarian Z, Sadat H, Leslie T. Crimean-Congo hemorrhagic fever, Afghanistan, 2009. Emerging Infectious Diseases 2011 Oct, 17(10): 1940-1941
Nalca A; Nichols DK. Rabbitpox: A model of airborne transmission of smallpox. Journal of General Virology 2011 Jan, 92(Pt 1): 31-5
Narayanan A, Popova T, Turell M, Kidd J, Chertow J, Popov SG, Bailey C, Kashanchi F, Kehn-Hall K. Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection. PLoS One 2011 May 18; 6(5): e20354
Nderitu L; Lee JS; Omolo J; Omulo S; O'Guinn ML; Hightower A; Mosha F; Mohamed M; Munyua P; Nganga Z; Hiett K; Seal B; Feikin DR; Breiman RF; Njenga MK. Sequential Rift Valley fever outbreaks in eastern Africa caused by multiple lineages of the virus. Journal of Infectious Diseases 2011 Jan 15, 203(5): 655-665
Okinaka RT, Price EP, Wolken SR, Gruendike JM, Chung WK, Pearson T, Xie G, Munk C, Hill KK, Challacombe J, Ivins BE, Schupp JM, Beckstrom-Sternberg SM, Friedlander A, Keim P. An attenuated strain of Bacillus anthracis (CDC 684) has a large chromosomal inversion and altered growth kinetics. BMC Genomics 2011 Sept 30; 12: 477
O'Leary VB, Ovsepian SV, Raghunath A, Huo Q, Lawrence GW, Smith L, Dolly JO. Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons. Gene Therapy 2011 July, 18(7): 656-665
Olson MA, Chaudhury S, Lee MS. Comparison Between Self-Guided Langevin Dynamics and Molecular Dynamics Simulations for Structure Refinement of Protein Loop Conformations. Journal of Computational Chemistry 2011 Nov 15, 32(14): 3014-3022
Opsenica I; Burnett JC; Gussio R; Opsenica D; Todorovic N; Lanteri CA; Sciotti RJ; Gettayacamin M; Basilico N; Taramelli D; Nuss JE; Wanner L; Panchal RG; Solaja BA; Bavari S. A Chemotype That inhibits three unrelated pathogenic targets: The Botulinum Neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus. Journal of Medicinal Chemistry 2011 Mar 10, 54(5): 1157-1169
Ou W, Delisle J, Konduru K, Bradfute S, Radoshitzky SR, Retterer C, Kota K, Bavari S, Kuhn JH, Jahrling PB, Kaplan G, Wilson CA. Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins. Journal of Virological Methods 2011 June; 174(1-2): 99-109
Pang Y-P, Park JG, Wang S, Vummenthala A, Mishra RK, McLaughlin JE, Di R, Kahn JN, Tumer NE, Janosi L, Davis J, Millard CB. Small-molecule inhibitor leads of Ribosome-inactivating proteins developed using the doorstop approach. PLoS One 2011 Mar 24; 6(3): e17883
Pawlowski DR; Metzger DJ; Raslawsky A; Howlett A; Siebert G; Karalus RJ; Garrett S; Whitehouse CA. Entry of Yersinia pestis into the viable but nonculturable state in a low-temperature tap water microcosm. PLoS One 2011 Mar 16, 6(3): e17585
Phoolcharoen W, Dye JM, Kilbourne J, Piensook K, Pratt WD, Arntzen CJ, Chen Q, Mason HS, Herbst-Kralovetz MM. A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. Proceedings of the National Academy of Science USA 2011 Dec 20; 108(51): 20695-700
Porter A, Phillips G, Smith L, Erwin-Cohen R, Tammariello R, Hale M, DaSilva L. Evaluation of a ricin vaccine candidate (RVEc) for human toxicity using an in vitro vascular leak assay. Toxicon 2011 July; 58(1): 68-75
Powell BS, Cybulski RJ. Inactivation and Extraction of Bacterial Spores for Systems Biological Analysis. IN: Edited by Ivanov AR, Lazarev AV. Sample Preparation in Biological Mass Spectrometry, 2011, Springer, New York, p.941-977
Radoshitzky SR, Longobardi LE, Kuhn JH, Retterer C, Dong L, Clester JC, Kota K, Carra J, Bavari S. Machupo virus glycoprotein determinants for human transferrin receptor 1 binding and cell entry. PloS One 2011; 6(7): e21398
Radoshitzky SR, Warfield KL, Chi XL, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH. Ebolavirus Delta-Peptide Immunoadhesins Inhibit Marburgvirus and Ebolavirus Cell Entry. Journal of Virology 2011 Sept, 85(17): 8502-8513
Rasko DA, Worsham PL, Abshire TG, Stanley ST, Bannan JD, Wilson MR, Langham RJ, Decker RS, Jiang L, Read TD, Phillippy AM, Salzberg SL, Pop M, Van Ert MN, Kenefic LJ, Keim PS, Fraser-Liggett CM, Ravel J. Bacillus anthracis comparative genome analysis in support of the Amerithrax investigation. Proceedings of the National Academy of Science USA 2011 Mar 22; 108(12): 5027-32
Raymond J, Bradfute S, Bray M. Filovirus Infection of STAT-1 Knockout Mice. Journal of Infectious Diseases 2011 Nov; 204(Suppl 3): S986-S990
Reed DS, Lackemeyer MG, Garza NL, Sullivan LJ, Nichols DK. Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microbes and Infection 2011 Oct, 13(11): 930-936
Rubins KH; Hensley LE; Relman DA; Brown PO. Stunned silence: Gene expression programs in human cells infected with Monkeypox or Vaccinia Virus. PLoS One 2011 Jan 18, 6(1): e15615
Rusnak JM; Gibbs P; Boudreau E; Clizbe DP; Pittman P. Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study. Vaccine 2011 Apr 12, 29(17): 3222-9
Ruthel G, Burnett JC, Nuss JE, Wanner LM, Tressler LE, Torres-Melendez E, Sandwick SJ, Retterer CJ, Bavari S. Post-Intoxication Inhibition of Botulinum Neurotoxin Serotype A within Neurons by Small-Molecule, Non-Peptidic Inhibitors. Toxins 2011 Mar, 3(3): 207-17
Samy RP, Stiles BG, Gopalakrishnakone P, Chow VT. Antimicrobial Proteins from Snake Venoms: Direct Bacterial Damage and Activation of Innate Immunity Against Staphylococcus aureus Skin Infection. Current Medicinal Chemistry 2011 Nov 1; 18(33): 5104-13
Samy RP, Thwin MM, Stiles BG, Bow H, Chow VT, Gopalakrishnakone P. Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Current Topics Medicinal Chemistry 2011; 11(20): 2540-55
Shabman RS, Leung DW, Johnson J, Glennon N, Gulcicek EE, Stone KL, Leung L, Hensley L, Amarasinghe GK, Basler CF. DRBP76 Associates With Ebola Virus VP35 and Suppresses Viral Polymerase Function. Journal of Infectious Diseases 2011 Nov; 204(Suppl 3): S911-S918
Sharma A; Gupta P; Glass PJ; Parker MD; Maheshwari RK. Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: Implication in vaccine development. Vaccine 2011 Jan 29, 29(5): 953-959
Sheng ZM, Chertow DS, Ambroggio X, McCall S, Przygodzki RM, Cunningham RE, Maximova OA, Kash JC, Morens DM, Taubenberger JK. Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak. Proceedings of the National Academy of Sciences of the USA 2011 Sept 27, 108(39): 16416-16421
Shultz LD, Brehm MA, Bavari S, Greiner DL. Humanized mice as a preclinical tool for infectious disease and biomedical research. Annals of the New York Academy of Sciences 2011 Dec, 1245: 50-54
Shurtleff AC, Warren TK, Bavari S. Nonhuman primates as models for the discovery and development of ebolavirus therapeutics. Expert Opinion on Drug Discovery 2011 Mar; 6 (3): 233-250
Simpson-Holley M; Kedersha N; Dower K; Rubins KH; Anderson P; Hensley LE; Connor JH. Formation of antiviral cytoplasmic granules during Orthopoxvirus infection. Journal of Virology 2011 Feb, 85(4): 1581-1593
Sullivan NJ, Hensley L, Asiedu C, Geisbert TW, Stanley D, Johnson J, Honko A, Olinger G, Bailey M, Geisbert JB, Reimann KA, Bao S, Rao S, Roederer M, Jahrling PB, Koup RA, Nabel GJ. CD8(+) cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nature Medicine 2011 Sept, 17(9): 1128-1131
Swietnicki W, Carmany D, Retford M, Guelta M, Dorsey R, Bozue J, Lee MS, Olson MA. Identification of Small-Molecule Inhibitors of Yersinia pestis Type III Secretion System YscN ATPase. PLoS One 2011 May 18; 6(5): e19716
Terra JK, France B, Cote CK, Jenkins A, Bozue JA, Welkos SL, Bhargava R, Ho C-L, Mehrabian M, Pan C, Lusis AJ, Davis RC, LeVine SM, Bradley KA. Allelic variation on murine chromosome 11 modifies host inflammatory responses and resistance to bacillus anthracis. PLoS Pathogens 2011 Dec, 7 (12): e1002469
Tubaro A, Del Favero G, Beltramo D, Ardizzone M, Forino M, De Bortoli M, Pelin, M, Poli M, Bignami G, Ciminiello P, Sosa S. Acute oral toxicity in mice of a new palytoxin analog: 42-Hydroxy-palytoxin. Toxicon 2011 Apr; 57(5): 755-63
Turell M, Davé K, Mayda M, Parker Z, Coleman R, Davé S, Strickman D. Wicking assay for the rapid detection of rift valley fever viral antigens in mosquitoes (diptera: Culicidae). Journal of Medical Entomology 2011 May; 48(3): 628-33
Vernati G; Edwards WH; Rocke TE; Little SF; Andrews GP. Antigenic profiling of Yersinia pestis infection in the Wyoming coyote (Canis Latrans). Journal of Wildlife Diseases 2011 Jan, 47(1): 21-29
Wahl-Jensen V, Cann JA, Rubins KH, Huggins JW, Fisher RW, Johnson AJ, de Kok-Mercado F, Larsen T, Raymond JL, Hensley LE, Jahrling PB. Progression of Pathogenic Events in Cynomolgus Macaques Infected with Variola Virus. PLoS One 2011 Oct; 6 (10): e24832
Wanja E, Parker Z, Rowland T, Turell MJ, Clark JW, Davé K, Davé S, Sang R. Field evaluation of a wicking assay for the rapid detection of rift valley fever viral antigens in mosquitoes1. Journal of the American Mosquito Control Association 2011 Dec; 27 (4): 370-375
Weinstein SA, Stiles BG. A review of the epidemiology, diagnosis and evidence-based management of Mycoplasma genitalium. Sexual Health 2011 June; 8(2): 143-158
Welkos S, Cote CK, Hahn U, Shastak O, Jedermann J, Bozue J, Jung G, Ruchala P, Pratikhya P, Tang T, Lehrer RI, Beyer W. Humanized theta-Defensins (Retrocyclins) Enhance Macrophage Performance and Protect Mice from Experimental Anthrax Infections. Antimicrobial Agents and Chemotherapy 2011 Sept 11, 55(9): 4238-4250
Williamson ED, Packer PJ, Waters EL, Simpson AJ, Dyer D, Hartings J, Twenhafel N, Pitt MLM. Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague. Vaccine 2011 June 24, 29(29-30): 4771-4777
Wink DA, Hines HB, Cheng RYS, Switzer CH, Flores-Santana W, Vitek MP, Ridnour LA, Colton CA. Nitric oxide and redox mechanisms in the immune response. Journal of Leukocyte Biology 2011; 89(6): 873-891
Wolfe LL, Shenk TM, Powell B, Rocke TE. Assessment of a Recombinant F1-V Fusion Protein Vaccine Intended to Protect Canada Lynx (Lyns Canadensis) from Plague. Journal of Wildlife Diseases 2011 Oct; 47(4): 888-892
Wu SJ, Eiben CB, Carra JH, Huang I, Zong D, Liu PX, Wu CT, Nivala J, Dunbar J, Huber T, Senft J, Schokman R, Smith MD, Mills JH, Friedlander AM, Baker D, Siegel JB. Improvement of a Potential Anthrax Therapeutic by Computational Protein Design. Journal of Biological Chemistry 2011 Sept 16, 286(37): 32586-32592
Yakes BJ, DeGrasse SL, Poli M, Deeds JR. Antibody characterization and immunoassays for palytoxin using an SPR biosensor. Analytical and Bioanalytical Chemistry 2011 July; 400(9): 2865-2869
Yen JY, Garamszegi S, Geisbert JB, Rubins KH, Geisbert TW, Honko A, Xia Y, Connor JH, Hensley LE. Therapeutics of Ebola Hemorrhagic Fever: Whole-Genome Transcriptional Analysis of Successful Disease Mitigation. Journal of Infectious Diseases 2011 Nov; 204(Suppl 3): S1043-S1052
Zeitlin L, Pettitt J, Scully C, Bohorova N, Kim D, Pauly M, Hiatt A, Ngo L, Steinkellner H, Whaley KJ, Olinger GG. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proceedings of the National Academy of Science USA 2011 Dec 20; 108(51): 20690-4
Zumbrun EE, Friedman HM. An attenuated HSV-1 live virus vaccine candidate that is replication competent but defective in epithelial cell-to-cell and neuronal spread. Birkhauser Advances in Infectious Diseases 2011, 3: 223-236
2012 • 2011 • 2010 • 2009 • 2008 • 2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001 • 2000